Valuation Repligen Corporation

Stocks

Market Closed - Nasdaq 00:00:00 17/09/2026 +04			5-day change	1st Jan Change
172.91 ^USD	-1.04%		+4.76%	+5.52%

09-16	Repligen Corporation Announces Retirement of Karen A. Dawes from Board of Directors, Effective September 30, 2026	CI
09-09	Repligen Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 01:30 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	14,643	9,401	10,039	8,064	9,224	9,758	-	-
Change	-	-35.8%	6.78%	-19.67%	14.38%	5.79%	-	-
Enterprise Value (EV) ¹	14,405	9,062	9,357	7,833	9,200	9,493	9,320	9,096
Change	-	-37.09%	3.26%	-16.29%	17.46%	3.19%	-1.82%	-2.4%
P/E	118x	52.3x	243x	-313x	191x	229x	100x	71.2x
PBR	8.67x	4.92x	5.09x	4.09x	4.38x	4.47x	4.17x	3.78x
PEG	-	1.2x	-3.1x	2x	-1x	-18.9x	1x	1.8x
Capitalization / Revenue	21.8x	11.7x	15.7x	12.7x	12.5x	11.8x	10x	8.52x
EV / Revenue	21.5x	11.3x	14.6x	12.3x	12.5x	11.5x	9.56x	7.94x
EV / EBITDA	62.5x	36.7x	73.1x	66.8x	65.6x	55.6x	42x	31.6x
EV / EBIT	66.9x	39x	99.2x	95.4x	90.4x	72.6x	52.6x	37.7x
EV / FCF	277x	104x	120x	52.3x	98x	78.7x	62.3x	45.7x
FCF Yield	0.36%	0.96%	0.83%	1.91%	1.02%	1.27%	1.6%	2.19%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	2.24	3.24	0.74	-0.46	0.86	0.756	1.728	2.429
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	670.5	801.5	638.8	634.4	738.3	826.9	974.4	1,145
EBITDA ¹	230.5	246.9	128	117.3	140.3	170.9	222.1	287.7
EBIT ¹	215.2	232.2	94.29	82.08	101.8	130.8	177	241.1
Net income ¹	128.3	186	41.58	-25.51	48.89	41.92	98.84	141.2
Net Debt ¹	-237.8	-339.1	-681.9	-231.8	-23.81	-264.9	-438	-662
Reference price ²	264.84	169.31	179.80	143.94	163.86	172.91	172.91	172.91
Nbr of stocks (in thousands)	55,289	55,524	55,832	56,027	56,291	56,436	-	-
Announcement Date	17/02/22	22/02/23	21/02/24	20/02/25	24/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REPLIGEN CORPORATION	228.73x	11.48x	55.56x	-.--%	9.76B
ABBOTT LABORATORIES	29x	4x	15.48x	2.51%	177B
MEDTRONIC PLC	19.59x	3.57x	12.77x	3.04%	118B
CENCORA, INC.	17.44x	0.2x	12.75x	0.75%	60.78B
BECTON, DICKINSON AND COMPANY	35.04x	3.4x	11.62x	2.16%	49.53B
HOYA CORPORATION	27.4x	6.74x	17.36x	1.46%	48.29B
DEXCOM, INC.	35.01x	6.16x	19.33x	-.--%	32.96B
MEDLINE INC.	42.59x	1.25x	11.58x	0.22%	28.94B
WEST PHARMACEUTICAL SERVICES, INC.	42.22x	7.4x	26.55x	0.25%	25.48B
SARTORIUS STEDIM BIOTECH	49.45x	6.68x	21.46x	0.43%	21.77B
Average	52.65x	5.09x	20.45x	1.08%	57.31B
Weighted average by Cap.	32.01x	4.05x	15.88x	1.83%